The Roswell Park Cancer Institute recently issued a press release about the potential for future breast cancer therapy that is tailored to each person's genetic makeup. The doctors at the institute indicated that genetic variations in tumors affects how each patient responds.
In response to the challenge this presents, researchers at the institute have developed a test that detects abnormal activity in the HER2 tumor cell gene. This test apparently helps determine if a patient is unlikely to respond to a specific anti-cancer drug. This looks like a great step in the right direction to personalized breast cancer therapy. You can read the full press release HERE.
Of course, the best 'therapy' is still prevention. My new book, Fight Now: Eat & Live Proactively Against Breast Cancer (www.fightBCnow.com) provides some key tips to reducing your breast cancer risk and provides a list of resources to enhance breast cancer awareness.